已收录 271055 条政策
 政策提纲
  • 暂无提纲
BIOTECHNOLOGY At the heart of gene edits in human embryos
[摘要] The gene-editing technology CRISPR-Cas has been used in human embryos grown in vitro to correct a disease-associated mutation. The introduction of editing components at fertilization aided repair efficiency. SEE ARTICLE P.413
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 
[关键词] PROTEIN;ZYGOTES [时效性] 
   浏览次数:1      统一登录查看全文      激活码登录查看全文